Sudeep Shivakumar - Division of ...

Dr. Sudeep Shivakumar, MD

Claim this profile

Queen Elizabeth II Health Sciences Centre

Studies Deep Vein Thrombosis
Studies Venous Thromboembolism
6 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.
Queen Elizabeth II Health Sciences Centre
Image of trial facility.
Queen Elizabeth II Hospital

Clinical Trials Sudeep Shivakumar, MD is currently running

Image of trial facility.

Statins

for Blood Clots

The standard or usual treatment for patients diagnosed with deep vein thrombosis or pulmonary embolism is treatment with blood thinners (called anticoagulants). While treatment of blood clots with blood thinners is effective, some research has shown that adding a statin (medication used to lower cholesterol) may give extra protection. It is thought that statins can improve how cells along the walls of the vein control inflammation, which can prevent new blood clots from forming. The medication in this study, rosuvastatin, is approved in Canada for use as a cholesterol-lowering medication. The use of rosuvastatin in this study is considered investigational. This means that Health Canada has not approved the use of rosuvastatin as a treatment for blood clots. However, it has been approved for use in this research study. The purpose of this study is to examine if adding a statin (rosuvastatin) to the usual blood thinner treatment will decrease the risk of another blood clot forming. The investigators also hope to discover if taking a statin reduces damage to your veins. To do this, some of the participants in this study will get rosuvastatin and others will receive a placebo (a substance that looks like the study rosuvastatin but does not have any active or medicinal ingredients). The placebo in this study is not intended to have any effect on your blood clot. A placebo is used to make the results of the study more reliable.
Recruiting1 award Phase 31 criteria
Image of trial facility.

Virtual Visits

for Atrial Fibrillation

The purpose of the PAUSE-Virtual Study is to show that by changing pre-surgery visits with patients taking a blood thinner (direct oral anticoagulant (apixaban, dabigatran, edoxaban, rivaroxaban or warfarin) when the participant requires elective surgery, using a standard, in-person proven approach, to a virtual visit, either telephone or video conference, is as safe. Patients who are receiving a blood thinner for the medical condition known as atrial fibrillation (AF) and require an elective surgery/procedure, is common. These patients have to stop taking their blood thinner for a certain time before the procedure to reduce serious complications of stroke or bleeding. For doctors who help manage these patients before a procedure, appointments have been traditionally done in-person. Patients receive instructions about when to stop and restart their blood thinners and taught how to self-administrator a short acting blood thinner (heparin) if needed. The COVID pandemic changed the way these appointments were done, making it important to contact these patients without them having to come to the hospital for an in person visit. Virtual patient care, by telephone or video conference, to communicate to patients about when to start and restart their blood thinner was necessary. This study wants to show that this virtual method of instruction, using a standardized plan of managing patient care, is easy, acceptable to patients and as safe when compared to an in-person meeting. Such instruction would also be cost-efficient standard post-pandemic. Prior work has shown that both a standard care of patients who are receiving blood thinners and a point-of-care decision "app", available through Thrombosis Canada (www.thrombosiscanada.ca) website, have been trusted during this virtual visit successfully. The investigator will show, by following up at 30 days, that this standardized management plan is safe and can be done virtually, with a low risk of stroke and major bleeding.
Recruiting1 award N/A2 criteria

More about Sudeep Shivakumar, MD

Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sudeep Shivakumar, MD has experience with
  • Apixaban
  • Abelacimab
  • Micronized Purified Flavonoid Fraction
  • Placebo
  • LEFt Clinical Decision Rule
  • Placebo Oral Tablet

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Sudeep Shivakumar, MD specialize in?
Is Sudeep Shivakumar, MD currently recruiting for clinical trials?
Are there any treatments that Sudeep Shivakumar, MD has studied deeply?
What is the best way to schedule an appointment with Sudeep Shivakumar, MD?
What is the office address of Sudeep Shivakumar, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security